Resources

Publish Date
Letters
C4IP Letter to Senate Judiciary Committee RE: Hearing on Patent Eligibility
Council for Innovation Promotion
Infographics
Idea Factories Report Infographic
Council for Innovation Promotion
Issue Briefs
Congress Should Pass PERA to Fix What the Supreme Court Unintentionally Broke
Council for Innovation Promotion
Public Comments
C4IP Comments RE: The Section 301 Investigation of Vietnam’s Acts, Policies, and Practices Related to Intellectual Property Protection (USTR-2026-0364)
Council for Innovation Promotion
Public Comments
C4IP Comments RE: The Section 301 Investigation of Brazil’s Acts, Policies, and Practices Related to Intellectual Property Protection (USTR-2026-0331)
Council for Innovation Promotion
Letters
C4IP Letter to House Judiciary Subcommittee on Courts, Intellectual Property, Artificial Intelligence, and the Internet RE: Hearing on IP and the Internet
Council for Innovation Promotion
Letters
C4IP Letter to Senate Finance Committee RE: Nomination of Peter-Anthony Pappas to the U.S. International Trade Commission
Council for Innovation Promotion
Letters
C4IP Letter to Senate HELP Committee RE: Consideration of Medication Affordability and Patent Integrity Act
Council for Innovation Promotion
Letters
C4IP Letter to Senate HELP Committee RE: Medication Affordability and Patent Integrity Act Markup
Council for Innovation Promotion
External ResourcesReports
Idea Factories: How Intellectual Property Sustains and Cultivates Technology Ecosystems
Professor Jonathan Barnett
Letters
C4IP Letter to House Judiciary Subcommittee on Courts, Intellectual Property, Artificial Intelligence, and the Internet RE: Hearing on Medicines and IP
Council for Innovation Promotion
Issue Briefs
Myths vs. Facts: Terminal Disclaimers
Council for Innovation Promotion
Resources:

Resources:

Patent Quality in the United States,

10/07/2024

Resources:

Resources:

C4IP Comments RE: Experimental Use Exception Request for Comments (PTO-C-2024-0023),

09/26/2024

Resources:

Resources:

C4IP Letter to Senate HELP Committee RE: Hearing on The Medication Affordability and Patent Integrity Act,

09/25/2024

Resources:

Resources:

C4IP Letter to Senate Judiciary Committee RE: PERA,

09/24/2024

Resources:

Resources:

C4IP Letter to Senate Judiciary Committee RE: PERA, PREVAIL Act, and IDEA Act,

09/18/2024

Resources:

Resources:

C4IP Letter to Senate Judiciary Committee RE: IDEA Act,

09/17/2024

Resources:

Resources:

C4IP Comments RE: 2024 Guidance Update on Patent Subject Matter Eligibility, Including on Artificial Intelligence (PTO-P-2024-0026),

09/16/2024

Resources:

Resources:

Overview of the USPTO Drug Exclusivity Report,

09/12/2024

Resources:

Resources:

C4IP Letter to Senate HELP Committee RE: The Medication Affordability and Patent Integrity Act,

08/26/2024

Resources:

Resources:

C4IP Comments RE: The Impact of the Proliferation of Artificial Intelligence on Prior Art, the Knowledge of a Person Having Ordinary Skill in the Art, and Determinations of Patentability Made in View of the Foregoing (PTO-P-2023-0044),

07/29/2024

Resources:

Resources:

C4IP Letter to House Judiciary Committee RE: IP Litigation and the U.S. International Trade Commission,

07/22/2024

Resources:

Resources:

C4IP Comments RE: Terminal Disclaimer Practice to Obviate Nonstatutory Double Patenting (PTO-P-2024-0003),

07/09/2024

Scroll to Top